ARVO is hosting its first Capitol Hill Congressional briefing on Dec. 7. The briefing will focus on OCT (optical coherence tomography) and how its incorporation into managing a potentially blinding disease, wet age-related macular degeneration, has cut unncessary healthcare spending.
Featured speakers at the briefing include:
Claude Burgoyne, MD, FARVO, Devers Eye Institute and ARVO President
Philip Rosenfeld, MD, PhD, Bascom Palmer Eye Institute
Eric Swanson, Massachusetts Institute of Technology
An OCT instrument from Leica Microsystems will be present for audience members to have their retina's imaged.
This widely attended event is held in conjunction with the Alliance for Eye and Vision Research, with special support from Research to Prevent Blindness.